This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Gilead Sciences, Inc.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Paul Bernard Hurley: Innovator in Pharmaceutical Science
Introduction
Paul Bernard Hurley is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of pharmaceutical science, particularly in the development of solid forms of tenofovir. His work has implications for the treatment of various medical conditions, showcasing the importance of innovation in healthcare.
Latest Patents
Hurley holds a patent for "Solid forms of tenofovir." This invention relates to solid forms of tenofovir and methods for preparation, use, and isolation of such forms. His patent is a testament to his expertise and dedication to advancing pharmaceutical formulations.
Career Highlights
Paul Bernard Hurley is associated with Gilead Sciences, Inc., a leading biopharmaceutical company. His role at Gilead has allowed him to work on groundbreaking research and development projects that aim to improve patient outcomes through innovative drug formulations.
Collaborations
Throughout his career, Hurley has collaborated with talented professionals, including Olga Viktorovna Lapina and Bing Shi. These collaborations have fostered a creative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical innovation.
Conclusion
In summary, Paul Bernard Hurley is a distinguished inventor whose work in solid forms of tenofovir has made a significant impact in the pharmaceutical industry. His contributions highlight the vital role of innovation in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile